Advertisement

Ventricular Assist Device Therapy in the Fontan Circulation

      The number of Fontan patients with circulatory failure and systolic dysfunction is growing rapidly. The last decade has demonstrated that ventricular assist device (VAD) is an effective therapy in properly selected patients. Herein, we discuss the current approach to patient selection, implantation, and patient management.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Fontan F
        • Baudet E.
        Surgical repair of tricuspid atresia.
        Thorax. 1971; 26: 240-248
        • d'Udekem Y
        • Iyengar AJ
        • Galati JC
        • et al.
        Redefining expectations of long-term survival after the Fontan procedure: Twenty-five years of follow-up from the entire population of Australia and New Zealand.
        Circulation. 2014; 130: S32-S38
        • Dennis M
        • Zannino D
        • du Plessis K
        • et al.
        Clinical outcomes in adolescents and adults after the Fontan procedure.
        J Am Coll Cardiol. 2018; 71: 1009-1017
        • Pundi KN
        • Johnson JN
        • Dearani JA
        • et al.
        40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients.
        J Am Coll Cardiol. 2015; 66: 1700-1710
        • Khairy P
        • Fernandes SM
        • Mayer JE
        • et al.
        Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.
        Circulation. 2008; 117: 85-92
        • Akintoye E
        • Miranda WR
        • Veldtman GR
        • et al.
        National trends in Fontan operation and in-hospital outcomes in the USA.
        Heart. 2019; 105: 708-714
        • Deshaies C
        • Hamilton RM
        • Shohoudi A
        • et al.
        Thromboembolic risk after atriopulmonary, lateral tunnel, and extracardiac conduit Fontan surgery.
        J Am Coll Cardiol. 2019; 74: 1071-1081
        • Sharma VJ
        • Iyengar AJ
        • Zannino D
        • et al.
        Protein-losing enteropathy and plastic bronchitis after the Fontan procedure.
        J Thorac Cardiovasc Surg. 2020; (S0022-5223(20)32359-X. EPUB.)
        • Moon J
        • Shen L
        • Likosky DS
        • et al.
        Relationship of ventricular morphology and atrioventricular valve function to long-term outcomes following Fontan procedures.
        J Am Coll Cardiol. 2020; 76: 419-431
        • Diller GP
        • Giardini A
        • Dimopoulos K
        • et al.
        Predictors of morbidity and mortality in contemporary Fontan patients: Results from a multicenter study including cardiopulmonary exercise testing in 321 patients.
        Eur Heart J. 2010; 31: 3073-3083
        • Diller GP
        • Kempny A
        • Alonso-Gonzalez R
        • et al.
        Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre.
        Circulation. 2015; 132: 2118-2125
        • Kanter KR
        • Mahle WT
        • Vincent RN
        • et al.
        Heart transplantation in children with a Fontan procedure.
        Ann Thorac Surg. 2011; 91 (discussion 829–30): 823-829
        • Lamour JM
        • Kanter KR
        • Naftel DC
        • et al.
        The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease.
        J Am Coll Cardiol. 2009; 54: 160-165
        • Doumouras BS
        • Alba AC
        • Foroutan F
        • et al.
        Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis.
        J Heart Lung Transplant. 2016; 35: 1337-1347
        • Zomer AC
        • Vaartjes I
        • van der Velde ET
        • et al.
        Heart failure admissions in adults with congenital heart disease; risk factors and prognosis.
        Int J Cardiol. 2013; 168: 2487-2493
        • Lal S
        • Kotchetkova I
        • Cao J
        • et al.
        Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease.
        Eur J Heart Fail. 2018; 20: 812-815
        • Everitt MD
        • Donaldson AE
        • Stehlik J
        • et al.
        Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS).
        J Heart Lung Transplant. 2011; 30: 395-401
        • Alshawabkeh L
        • Opotowsky AR
        • Carter KD
        • et al.
        Disparities in wait-list outcomes for adults with congenital heart disease listed for heart transplantation before and since revision of status I listing.
        Am J Cardiol. 2018; 122: 1761-1764
        • Krishnamurthy Y
        • Cooper LB
        • Lu D
        • et al.
        Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
        J Heart Lung Transplant. 2016; 35: 619-624
        • Morales DLS
        • Rossano JW
        • VanderPluym C
        • et al.
        Third annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: Preimplant characteristics and outcomes.
        Ann Thorac Surg. 2019; 107: 993-1004
        • Kormos RL
        • Cowger J
        • Pagani FD
        • et al.
        The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving indications, outcomes, and scientific partnerships.
        Ann Thorac Surg. 2019; 107: 341-353
        • Almond CS
        • Morales DL
        • Blackstone EH
        • et al.
        Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.
        Circulation. 2013; 127: 1702-1711
        • Kittleson MM
        • Shah P
        • Lala A
        • et al.
        INTERMACS profiles and outcomes of ambulatory advanced heart failure patients: A report from the REVIVAL Registry.
        J Heart Lung Transplant. 2020; 39: 16-26
        • Rychik J
        • Atz AM
        • Celermajer DS
        • et al.
        Evaluation and management of the child and adult with Fontan circulation: A scientific statement from the American Heart Association.
        Circulation. 2019;
        • Panchangam C
        • White DA
        • Goudar S
        • et al.
        Translation of the frailty paradigm from older adults to children with cardiac disease.
        Pediatr Cardiol. 2020; 41: 1031-1041
        • Moore BM
        • Anderson R
        • Nisbet AM
        • et al.
        Ablation of atrial arrhythmias after the atriopulmonary Fontan procedure: Mechanisms of arrhythmia and outcomes.
        JACC Clin Electrophysiol. 2018; 4: 1338-1346
        • Giannakoulas G
        • Dimopoulos K
        • Yuksel S
        • et al.
        Atrial tachyarrhythmias late after Fontan operation are related to increase in mortality and hospitalization.
        Int J Cardiol. 2012; 157: 221-226
        • Grubb CS
        • Lewis M
        • Whang W
        • et al.
        Catheter ablation for atrial tachycardia in adults with congenital heart disease: Electrophysiological predictors of acute procedural success and post-procedure atrial tachycardia recurrence.
        JACC Clin Electrophysiol. 2019; 5: 438-447
        • Egbe AC
        • Connolly HM
        • Khan AR
        • et al.
        Outcomes in adult Fontan patients with atrial tachyarrhythmias.
        Am Heart J. 2017; 186: 12-20
        • Egbe AC
        • Connolly HM
        • McLeod CJ
        • et al.
        Thrombotic and embolic complications associated with atrial arrhythmia after Fontan operation: Role of prophylactic therapy.
        J Am Coll Cardiol. 2016; 68: 1312-1319
        • Poh C
        • Hornung T
        • Celermajer DS
        • et al.
        Modes of late mortality in patients with a Fontan circulation.
        Heart. 2020; 106: 1427-1431
        • Deal BJ
        • Costello JM
        • Webster G
        • et al.
        Intermediate-term outcome of 140 consecutive Fontan conversions with arrhythmia operations.
        Ann Thorac Surg. 2016; 101: 717-724
        • Ono M
        • Cleuziou J
        • Pabst von Ohain J
        • et al.
        Atrioventricular valve regurgitation in patients undergoing total cavopulmonary connection: Impact of valve morphology and underlying mechanisms on survival and reintervention.
        J Thorac Cardiovasc Surg. 2018; 155: 701-709 e6
        • Kotani Y
        • Chetan D
        • Atlin CR
        • et al.
        Longevity and durability of atrioventricular valve repair in single-ventricle patients.
        Ann Thorac Surg. 2012; 94: 2061-2069
        • Khiabani RH
        • Whitehead KK
        • Han D
        • et al.
        Exercise capacity in single-ventricle patients after Fontan correlates with haemodynamic energy loss in TCPC.
        Heart. 2015; 101: 139-143
        • Whitehead KK
        • Pekkan K
        • Kitajima HD
        • et al.
        Nonlinear power loss during exercise in single-ventricle patients after the Fontan: Insights from computational fluid dynamics.
        Circulation. 2007; 116: I165-I171
        • Rodefeld MD
        • Marsden A
        • Figliola R
        • et al.
        Cavopulmonary assist: Long-term reversal of the Fontan paradox.
        J Thorac Cardiovasc Surg. 2019; 158: 1627-1636
        • Dori Y
        • Keller MS
        • Rome JJ
        • et al.
        Percutaneous lymphatic embolization of abnormal pulmonary lymphatic flow as treatment of plastic bronchitis in patients with congenital heart disease.
        Circulation. 2016; 133: 1160-1170
        • Maleux G
        • Storme E
        • Cools B
        • et al.
        Percutaneous embolization of lymphatic fistulae as treatment for protein-losing enteropathy and plastic bronchitis in patients with failing Fontan circulation.
        Catheter Cardiovasc Interv. 2019;
        • Itkin M
        • Piccoli DA
        • Nadolski G
        • et al.
        Protein-losing enteropathy in patients with congenital heart disease.
        J Am Coll Cardiol. 2017; 69: 2929-2937
        • John AS
        • Johnson JA
        • Khan M
        • et al.
        Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation.
        J Am Coll Cardiol. 2014; 64: 54-62
        • Dunlay SM
        • Park SJ
        • Joyce LD
        • et al.
        Frailty and outcomes after implantation of left ventricular assist device as destination therapy.
        J Heart Lung Transplant. 2014; 33: 359-365
        • Rodriguez de Santiago E
        • Tellez L
        • Garrido-Lestache Rodriguez-Monte E
        • et al.
        Fontan protein-losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state.
        Liver Int. 2020; 40: 638-645
        • Hraska V
        Decompression of thoracic duct: New approach for the treatment of failing Fontan.
        Ann Thorac Surg. 2013; 96: 709-711
        • Bauer C
        • Mair R
        • Mair R
        • et al.
        Thoracic duct decompression and jugular vein banding-an effective treatment option for protein-losing enteropathy and plastic bronchitis in severe failing Fontan circulation: A case report.
        Eur Heart J Case Rep. 2020; 4: 1-4
        • Egbe AC
        • Poterucha JT
        • Warnes CA
        • et al.
        Hepatocellular carcinoma after Fontan operation.
        Circulation. 2018; 138: 746-748
        • Trusty PM
        • Wei Z
        • Rychik J
        • et al.
        Impact of hemodynamics and fluid energetics on liver fibrosis after Fontan operation.
        J Thorac Cardiovasc Surg. 2018; 156: 267-275
        • Goldberg DJ
        • Surrey LF
        • Glatz AC
        • et al.
        Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: A liver biopsy and hemodynamic study.
        J Am Heart Assoc. 2017; 6: e004809
        • Emamaullee J
        • Zaidi AN
        • Schiano T
        • et al.
        Fontan-associated liver disease: Screening, management, and transplant considerations.
        Circulation. 2020; 142: 591-604
        • Possner M
        • Gordon-Walker T
        • Egbe AC
        • et al.
        Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.
        Int J Cardiol. 2020;
        • Daniels CJ
        • Bradley EA
        • Landzberg MJ
        • et al.
        Fontan-associated liver disease: Proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC.
        J Am Coll Cardiol. 2017; 70: 3173-3194
        • Simpson KE
        • Esmaeeli A
        • Khanna G
        • et al.
        Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.
        J Heart Lung Transplant. 2014; 33: 170-177
        • Greenway SC
        • Crossland DS
        • Hudson M
        • et al.
        Fontan-associated liver disease: Implications for heart transplantation.
        J Heart Lung Transplant. 2016; 35: 26-33
        • Munsterman ID
        • Duijnhouwer AL
        • Kendall TJ
        • et al.
        The clinical spectrum of Fontan-associated liver disease: Results from a prospective multimodality screening cohort.
        Eur Heart J. 2019; 40: 1057-1068
        • Wu FM
        • Kogon B
        • Earing MG
        • et al.
        Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
        J Thorac Cardiovasc Surg. 2017; 153: 656-664
        • Vaikunth SS
        • Higgins JP
        • Concepcion W
        • et al.
        Does liver biopsy accurately measure fibrosis in Fontan-associated liver disease? A comparison of liver biopsy pre-combined heart and liver transplant and liver explant post-transplant.
        Clin Transplant. 2020; 34: e14120
        • Cotter TG
        • Wang J
        • Peeraphatdit T
        • et al.
        Simultaneous heart-liver transplantation for congenital heart disease in the USA: Rapidly increasing with acceptable outcomes.
        Hepatology. 2020;
        • Hollander SA
        • Reinhartz O
        • Maeda K
        • et al.
        Intermediate-term outcomes after combined heart-liver transplantation in children with a univentricular heart.
        J Heart Lung Transplant. 2013; 32: 368-370
        • Opotowsky AR
        • Baraona FR
        • Mc Causland FR
        • et al.
        Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
        Heart. 2017; 103: 434-442
        • Lee D
        • Levin A
        • Kiess M
        • et al.
        Chronic kidney damage in the adult Fontan population.
        Int J Cardiol. 2018; 257: 62-66
        • Cordina R
        • O'Meagher S
        • Gould H
        • et al.
        Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation.
        Heart. 2013; 99: 1530-1534
        • Kirelik D
        • Fisher M
        • DiMaria M
        • et al.
        Comparison of creatinine and cystatin C for estimation of glomerular filtration rate in pediatric patients after Fontan operation.
        Congenit Heart Dis. 2019;
        • Vukicevic M
        • Mosadegh B
        • Min JK
        • et al.
        Cardiac 3D printing and its future directions.
        JACC Cardiovasc Imaging. 2017; 10: 171-184
        • Moore RA
        • Lorts A
        • Madueme PC
        • et al.
        Virtual implantation of the 50cc SynCardia total artificial heart.
        J Heart Lung Transplant. 2016; 35: 824-827
        • Moore RA
        • Madueme PC
        • Lorts A
        • et al.
        Virtual implantation evaluation of the total artificial heart and compatibility: Beyond standard fit criteria.
        J Heart Lung Transplant. 2014; 33: 1180-1183
        • Bouhout I
        • Ben-Ali W
        • Khalaf D
        • et al.
        Effect of fenestration on Fontan procedure outcomes: A meta-analysis and review.
        Ann Thorac Surg. 2020; 109: 1467-1474
        • Averin K
        • Hirsch R
        • Seckeler MD
        • et al.
        Diagnosis of occult diastolic dysfunction late after the Fontan procedure using a rapid volume expansion technique.
        Heart. 2016; 102: 1109-1114
        • Cedars A
        • Vanderpluym C
        • Koehl D
        • et al.
        An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease.
        J Heart Lung Transplant. 2018; 37: 619-630
        • Gelow JM
        • Song HK
        • Weiss JB
        • et al.
        Organ allocation in adults with congenital heart disease listed for heart transplant: Impact of ventricular assist devices.
        J Heart Lung Transplant. 2013; 32: 1059-1064
        • Alshawabkeh LI
        • Hu N
        • Carter KD
        • et al.
        Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the US.
        J Am Coll Cardiol. 2016; 68: 908-917
        • Chau P
        • Lim HM
        • Schumacher KR
        • et al.
        Use of hemodynamic ramp study to optimize continuous-flow ventricular assist device in a Fontan patient.
        ASAIO J. 2019; 65: e47-e49
        • Imielski BR
        • Niebler RA
        • Kindel SJ
        • et al.
        HeartWare ventricular assist device implantation in patients with Fontan physiology.
        Artif Organs. 2017; 41: 40-46
        • VanderPluym CJ
        • Cedars A
        • Eghtesady P
        • et al.
        Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
        J Heart Lung Transplant. 2018; 37: 89-99
        • Riggs KW
        • Lorts A
        • Villa CR
        • et al.
        The right tool for the right job: Bridging a failing Fontan to transplant.
        Ann Thorac Surg. 2018; 106: e145-e146
        • Chen S
        • Rosenthal DN
        • Murray J
        • et al.
        Bridge to transplant with ventricular assist device support in pediatric patients with single ventricle heart disease.
        ASAIO J. 2020; 66: 205-211
        • Lorts A
        • Villa C
        • Riggs KW
        • et al.
        First use of HeartMate 3 in a failing Fontan circulation.
        Ann Thorac Surg. 2018; 106: e233-e234
        • Cedars AM
        • Schumacher K
        • Kindel S
        • et al.
        The Fontan VAD Physiology Project (FVPP).
        J Heart Lung Transplant. 2020; 39: S12-S13
        • Ait Ali L
        • Cadoni A
        • Rossi G
        • et al.
        Effective cardiac index and systemic-pulmonary collaterals evaluated by cardiac magnetic resonance late after Fontan palliation.
        Am J Cardiol. 2017; 119: 2069-2072
        • Latus H
        • Gummel K
        • Diederichs T
        • et al.
        Aortopulmonary collateral flow is related to pulmonary artery size and affects ventricular dimensions in patients after the Fontan procedure.
        PLoS One. 2013; 8: e81684
        • Uriel N
        • Adatya S
        • Maly J
        • et al.
        Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3).
        J Heart Lung Transplant. 2017; 36: 28-35
        • Rossano JW
        • Goldberg DJ
        • Fuller S
        • et al.
        Successful use of the total artificial heart in the failing Fontan circulation.
        Ann Thorac Surg. 2014; 97: 1438-1440
        • Woods RK
        • Niebler R
        • Kindel S
        • et al.
        A new method for implanting a total artificial heart in the patient with a Fontan circulation.
        J Thorac Cardiovasc Surg. 2019; 157: 353-355
        • Peng DM
        • Koehl DA
        • Cantor RS
        • et al.
        Outcomes of children with congenital heart disease implanted with ventricular assist devices: An analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs).
        J Heart Lung Transplant. 2019; 38: 420-430
        • Riggs KW
        • Zafar F
        • Lorts A
        • et al.
        Optimizing postcardiac transplantation outcomes in children with ventricular assist devices: How long should the bridge be?.
        ASAIO J. 2020; 66: 787-795